{
    "study_accession": "SDY508",
    "actual_completion_date": null,
    "actual_enrollment": 12,
    "actual_start_date": "2012-02-01",
    "age_unit": "Years",
    "brief_description": "Integrate two high-throughput technologies namely, microengraving-based screening of primary B cells and next-generation sequencing to examine the relationship between the diversity and quality of humoral responses raised and the severity of disease.",
    "brief_title": "Humoral responses to West Nile virus",
    "clinical_trial": "N",
    "condition_studied": "Antibody responses to infection with West Nile virus",
    "dcl_id": 2,
    "description": "Integrate two high-throughput technologies namely, microengraving-based screening of primary B cells and next-generation sequencing to examine the relationship between the diversity and quality of humoral responses raised and the severity of disease.",
    "doi": "10.21430/M3WVUCYBW9",
    "endpoints": "Next-generation sequencing for pools of B cells isolated from subject.",
    "gender_included": "Female, Male",
    "hypothesis": "We hypothesize that differential production of antibody responses, limited clonotypic diversity, isotype biasing, or lower quality (affinity) antibodies may be key components of susceptibility to severe disease.",
    "initial_data_release_date": "2016-03-18",
    "initial_data_release_version": "DR18",
    "intervention_agent": null,
    "latest_data_release_date": "2016-03-18",
    "latest_data_release_version": "DR18",
    "maximum_age": "  67.00",
    "minimum_age": "  20.00",
    "objectives": "Determine how humoral responses relate to severity of disease to provide insight to predicting outcomes.",
    "official_title": "High-throughput immunophenotypic analyses of humoral responses to West Nile virus",
    "sponsoring_organization": "NIAID",
    "target_enrollment": null,
    "workspace_id": 2412,
    "research_focus": [
        "Immune Response"
    ],
    "arm": [
        {
            "arm_accession": "ARM2579",
            "description": "WNV+; severe",
            "name": "Severe"
        },
        {
            "arm_accession": "ARM2580",
            "description": "WNV+; asymptomatic",
            "name": "Asymptomatic"
        }
    ],
    "personnel": [
        {
            "first_name": "David",
            "last_name": "Hafler",
            "organization": "Yale",
            "role_in_study": "Principal Investigator",
            "site_name": "Yale"
        }
    ],
    "pubmed": [],
    "program": [
        {
            "program_name": "Human Immunology Project Consortium (HIPC) RFA-AI-14-007",
            "contract_name": "Defining signatures for immune responsiveness by functional systems immunology HIPC1"
        }
    ],
    "assay": [
        {
            "measurement_technique": "Sequencing",
            "number_of_expsamples": 19
        }
    ],
    "subject": {
        "race": [
            {
                "race": "Black or African American",
                "count": 1
            },
            {
                "race": "White",
                "count": 11
            }
        ],
        "gender": [
            {
                "Female": 6
            },
            {
                "Male": 6
            }
        ]
    }
}
